157 related articles for article (PubMed ID: 11751074)
21. PHEX expression in parathyroid gland and parathyroid hormone dysregulation in X-linked hypophosphatemia.
Blydt-Hansen TD; Tenenhouse HS; Goodyer P
Pediatr Nephrol; 1999 Sep; 13(7):607-11. PubMed ID: 10460513
[TBL] [Abstract][Full Text] [Related]
22. Developmental expression and tissue distribution of Phex protein: effect of the Hyp mutation and relationship to bone markers.
Ruchon AF; Tenenhouse HS; Marcinkiewicz M; Siegfried G; Aubin JE; DesGroseillers L; Crine P; Boileau G
J Bone Miner Res; 2000 Aug; 15(8):1440-50. PubMed ID: 10934642
[TBL] [Abstract][Full Text] [Related]
23. ASARM peptides: PHEX-dependent and -independent regulation of serum phosphate.
David V; Martin A; Hedge AM; Drezner MK; Rowe PS
Am J Physiol Renal Physiol; 2011 Mar; 300(3):F783-91. PubMed ID: 21177780
[TBL] [Abstract][Full Text] [Related]
24. Dietary phosphorus and 1,25-dihydroxyvitamin D metabolism: influence of insulin-like growth factor I.
Halloran BP; Spencer EM
Endocrinology; 1988 Sep; 123(3):1225-9. PubMed ID: 3402383
[TBL] [Abstract][Full Text] [Related]
25. Local action of exogenous growth hormone and insulin-like growth factor-I on dihydroxyvitamin D production in LLC-PK1 cells.
Wei S; Tanaka H; Seino Y
Eur J Endocrinol; 1998 Oct; 139(4):454-60. PubMed ID: 9820625
[TBL] [Abstract][Full Text] [Related]
26. Exogenous 1,25-dihydroxyvitamin D3 exerts a skeletal anabolic effect and improves mineral ion homeostasis in mice that are homozygous for both the 1alpha-hydroxylase and parathyroid hormone null alleles.
Xue Y; Karaplis AC; Hendy GN; Goltzman D; Miao D
Endocrinology; 2006 Oct; 147(10):4801-10. PubMed ID: 16857747
[TBL] [Abstract][Full Text] [Related]
27. Effect of testosterone on insulin-like growth factor-I (IGF-I) and IGF-I receptor gene expression in the hypophysectomized rat.
Phillip M; Palese T; Hernandez ER; Roberts CT; LeRoith D; Kowarski AA
Endocrinology; 1992 May; 130(5):2865-70. PubMed ID: 1315260
[TBL] [Abstract][Full Text] [Related]
28. Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin D-1alpha-hydroxylase expression in vitro.
Perwad F; Zhang MY; Tenenhouse HS; Portale AA
Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1577-83. PubMed ID: 17699549
[TBL] [Abstract][Full Text] [Related]
29. A novel Phex mutation in a new mouse model of hypophosphatemic rickets.
Owen C; Chen F; Flenniken AM; Osborne LR; Ichikawa S; Adamson SL; Rossant J; Aubin JE
J Cell Biochem; 2012 Jul; 113(7):2432-41. PubMed ID: 22573557
[TBL] [Abstract][Full Text] [Related]
30. Effects of unilateral arterial infusion of GH and IGF-I on tibial longitudinal bone growth in hypophysectomized rats.
Nilsson A; Isgaard J; Lindahl A; Peterson L; Isaksson O
Calcif Tissue Int; 1987 Feb; 40(2):91-6. PubMed ID: 3105839
[TBL] [Abstract][Full Text] [Related]
31. Chronic inhibition of ERK1/2 signaling improves disordered bone and mineral metabolism in hypophosphatemic (Hyp) mice.
Zhang MY; Ranch D; Pereira RC; Armbrecht HJ; Portale AA; Perwad F
Endocrinology; 2012 Apr; 153(4):1806-16. PubMed ID: 22334725
[TBL] [Abstract][Full Text] [Related]
32. Effects of insulin--like growth factor-I treatment on the endocrine pancreas of hypophysectomized rats: comparison with growth hormone replacement.
Jevdjovic T; Maake C; Eppler E; Zoidis E; Reinecke M; Zapf J
Eur J Endocrinol; 2004 Aug; 151(2):223-31. PubMed ID: 15296478
[TBL] [Abstract][Full Text] [Related]
33. Reduced ob mRNA in hypophysectomised rats is not restored by growth hormone (GH), but further suppressed by exogenously administered insulin-like growth factor (IGF) I.
Böni-Schnetzler M; Gosteli-Peter MA; Moritz W; Froesch ER; Zapf J
Biochem Biophys Res Commun; 1996 Aug; 225(1):296-301. PubMed ID: 8769133
[TBL] [Abstract][Full Text] [Related]
34. X-linked hypophosphataemia: a homologous disorder in humans and mice.
Tenenhouse HS
Nephrol Dial Transplant; 1999 Feb; 14(2):333-41. PubMed ID: 10069185
[TBL] [Abstract][Full Text] [Related]
35. Modulation of CYP27B1 and CYP24 mRNA expression in bone is independent of circulating 1,25(OH)2D3 levels.
Anderson PH; O'Loughlin PD; May BK; Morris HA
Bone; 2005 Apr; 36(4):654-62. PubMed ID: 15781002
[TBL] [Abstract][Full Text] [Related]
36. Ontogeny and pituitary regulation of testicular growth hormone-releasing hormone-like messenger ribonucleic acid.
Berry SA; Pescovitz OH
Endocrinology; 1990 Sep; 127(3):1404-11. PubMed ID: 2201537
[TBL] [Abstract][Full Text] [Related]
37. Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice.
Chow EC; Quach HP; Vieth R; Pang KS
Am J Physiol Endocrinol Metab; 2013 May; 304(9):E977-89. PubMed ID: 23482451
[TBL] [Abstract][Full Text] [Related]
38. Thyroid hormone and growth hormone interact to regulate insulin-like growth factor-I messenger ribonucleic acid and circulating levels in the rat.
Wolf M; Ingbar SH; Moses AC
Endocrinology; 1989 Dec; 125(6):2905-14. PubMed ID: 2583046
[TBL] [Abstract][Full Text] [Related]
39. A possible role of vitamin D receptors in regulating vitamin D activation in the kidney.
Iida K; Shinki T; Yamaguchi A; DeLuca HF; Kurokawa K; Suda T
Proc Natl Acad Sci U S A; 1995 Jun; 92(13):6112-6. PubMed ID: 7597089
[TBL] [Abstract][Full Text] [Related]
40. Growth hormone modulates cholecalciferol metabolism with moderate effects on intestinal mineral absorption and specific effects on bone formation in growing dogs raised on balanced food.
Tryfonidou MA; Holl MS; Oosterlaken-Dijksterhuis MA; Vastenburg M; van den Brom WE; Hazewinkel HA
Domest Anim Endocrinol; 2003 Aug; 25(2):155-74. PubMed ID: 12972373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
